Compounds that bind to p185 and methods of using the same

Details Compounds that bind to p185 and methods of using the same Compounds that bind to p185 and methods of using the same

1995-05-03

1997-09-02

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 13, 530324, 530325, 530326, 530327, 530328, A61K 3800

Patent

active

056631448

ABSTRACT:
Novels peptides and pharmaceutical compositions comprising the same are disclosed. Conjugated compositions peptides linked to detectable agents and/or cytotoxic agents. are disclosed. Method of detecting tumors that have p185 on tumor cell surfaces are disclosed. Methods of preventing transformation of a normal cell into a tumor cell in an individual at risk of developing a tumor having tumor cells which have p185 on their surfaces are disclosed. Methods of treating an individual who has cancer characterized by tumor cells that have a p185 on their cell surfaces are disclosed.

REFERENCES:
Bach, A. et al., "Structural Studies of Family of High Affinity LIgands for GP.sup.IIb/IIIa ", New Adv. Peptidomimetics Small Mol. Design 1994, 1, 1-26.
Bargmann, C. et al., "The Neu Oncogene Encodes an Epidermal Growth Factor Receptor-Related Protein", Nature 1986, 319, 226-230.
Bargmann, C. and Weinberg, R., "Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene", Proc. Natl. Acad. Sci. USA 1988, 85, 5394-5398.
Bookman, M.A. et al., "Immunotoxins Directed Against c-erbB2: Limited Activity Due to Poor Internalization", 3rd International Symposium on Immunotoxins, 1992, p. 15.
Di Blasio et al., "Noncoded Residues as Building Block in the Design of Specific Secondary Structures: Symmetrically Disubstituted Glycines and .beta.-Alanine", Biopolymers 1993, 33, 1037-1049.
Dougall, W. et al., "Modulation of p185-.sup.c-erB-2 Expression and Tumorigenic Growth by Anti-receptor Monoclonal Antibodies", J. of Cellular Biochem. 1994, Supplement 18D, No. Y 507, p. 252.
Drebin et al., "Down-Modulation of an Oncogene Protein Product and Reversion of the Transformed Phenotype by Monoclonal Antibodies", Cell 1985, 41, 695-706.
Drebin, J. et al., "Inhibition of Tumor Growth by a Monoclonal Antibody reactive with an Oncogene-Encoded Tumor Antigen", PNAS USA 1986, 83, 9129-9133.
Drebin, J. et al., "Monoclonal Antibodies Reactive with Distinct Domains of the Neu Oncogene-Encoded p185 Molecule Exert Synergistic Anti-Tumor Effects in Vivo", Oncogene 1988, 2, 273-277.
Hruby, V.J. et al., "Conformational and Topographical Considerations in the Design of Biologically Active Peptides", Biopolymers 1993, 33, 1073-1082.
Lodato, R.F. et al., "Immunohistochemical Evaluation of c-erbB-2 Oncogene Expression in Ductal Hyperplasia of the Breast", Modern Pathol. 1990, 3(4), 449-454.
Manning, M. et al., "Design of cyclic and linear peptide antagonists of vasopression and oxytocin: current status and future directions", Regulatory Peptides 1993, 45, 279-283.
Matsuyama, T. et al., "A Novel Extracellular Cyclic Lipopeptide Which Promotes Glagellum-Dependent and Independent Spreading Growth of Serratia marcescens", J. of Bacteriology 1992, 174, 1769-1776.
Saragovi, H. et al., "Design and Synthesis of a Mimetic from an Antibody Complementarity-determining Region", Science 1991, 253, 792-795.
Saragovi, H., "Constrained Peptides and Mimetics as Probes of Protein Secondary Structure", Immunomethods 1992, 1, 5-9.
Slamon, D.J., "Role of the HEr-2
eu Gene in Human Breast and Ovarian Cancer", Meetings of the American Association of Clinical Research, 1992.
Wada, T. et al., "Anti-receptor Antibodies Reverse the Phenotype of Cells Transformed by Two Interacting Proto-oncogene Encoded Receptor Proteins", Oncogene 1990, 5, 489-495.
Wood, S. and Wetzel, "Novel Cyclization Chemistry Especially Suited for Biologically Derived, Unprotected Peptides", Int. J. Peptide Protein Res. 1992, 39, 533-539.
Wright, C. et al., "Expression of c-erbB-2 Oncoprotein: A Prognostic Indicator in Human Breast Cancer", Cancer Research 1989, 49, 2087-2090.

Affiliated with

Also associated with

Rating

Compounds that bind to p185 and methods of using the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds that bind to p185 and methods of using the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds that bind to p185 and methods of using the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-308087